MENU

Demetris Afxentiou

How Fortis Inc. Can Power Your Portfolio to Growth

Unlike typical utilities, Fortis Inc. (TSX:FTS)(NYSE:FTS) offers investors strong growth, a great dividend, and plenty of long-term potential. More »

Why Bombardier Inc.’s Metrolinx Contract is so Important

Bombardier Inc. (TSX:BBD.B) received a favourable decision from an Ontario court this week, but the company now has to deliver its contractual obligations. More »

Cineplex Inc. Continues to Innovate and Grow

Cineplex Inc. (TSX:CGX) is a great investment that can offer investors significantly more than a movie and tub of popcorn. More »

Could Starting an Ultra Low-Cost Carrier Help WestJet Airlines Ltd.?

WestJet Airlines Ltd. (TSX:WJA) is preparing to launch an ultra-low cost carrier over the next year. Here’s what it means for WestJet and the... More »

4 Reasons to Add Bank of Montreal to Your Portfolio

Strong results, a great dividend, and impressive growth prospects are just some of the reasons investors should consider Bank of Montreal (TSX:BMO)(NYSE:BMO) More »

3 Great Canadian Tech Companies With Huge Potential

Sierra Wireless Inc. (TSX:SW)(NASDAQ:SWIR) and Amaya Inc. (TSX:AYA)(NYSE:AYA) are among the great tech stocks that hold plenty of potential More »

Which is the Better Telecom: Rogers Communications Inc. or Shaw Communications Inc.

Rogers Communications Inc. (TSX:RCI.B)(NYSE:RCI) and Shaw Communications Inc. (TSX:SJR.B)(NYSE:SJR) offer similar services to subscribers, but which of the two is the better investment? More »

3 Core Holdings With Massive Defensive Moats

BCE Inc. (TSX:BCE)(NYSE:BCE) and Bank of Montreal (TSX:BMO)(NYSE:BMO) are can offer investors growth, income, and a sizeable defensive moat. More »

Top 3 Reasons to Invest in Canadian National Railway Company

Canadian National Railway Company (TSX:CNR)(NYSE:CNI) can provide growth and income prospects to investors thanks to an efficient and diversified business model. More »

Valeant Pharmaceuticals Intl Inc.: Is a Recovery Possible?

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has to address a growing number of long-standing issues before it can be considered a viable investment option. More »